1 company and 1 research report found for "Ardelyx"
No sector reports have been found.
Phase IIb data in constipation-IBS for phosphate-sodium absorption inhibitor tenapanor was positive at the highest dose and a decision to proceed to P...
Forgotten your login?
Registered office: Edison Investment Research Limited, 280 High Holborn, London, WC1V 7EE UK. Company no. 4794244. VAT no. 815041270
© 2017 All rights reserved. Edison Investment Research is authorised and regulated by the Financial Conduct Authority.
This site requires cookies in order to give you the best user experience.
Find out more